Literature DB >> 6182748

Characterization of two substance P antisera.

E Brodin, G Nilsson, K Folkers.   

Abstract

The cross reactivity of two currently used substance P (SP) antisera (K 16 and K 25) with various analogues of SP, partial sequences of SP and other naturally occurring peptides were tested in a radioimmunoassay system. Both antisera were found to be C-terminal directed, this tendency being most pronounced for antiserum K 16. The capacity of antiserum K 25 to bind various SP-related peptides correlated to the previously described biological activity of these peptides on the isolated guinea pig ileum. The results thus indicate that this antiserum binds to a biologically active part of the SP-molecule.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182748     DOI: 10.1111/j.1748-1716.1982.tb06951.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  4 in total

1.  Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.

Authors:  K Iverfeldt; L L Peterson; E Brodin; S O Ogren; T Bartfai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

2.  Peptide-containing nerve fibres in the gut wall in Crohn's disease.

Authors:  K Sjölund; O B Schaffalitzky; D E Muckadell; J Fahrenkrug; R Håkanson; B G Peterson; F Sundler
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

3.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

Authors:  J M Lundberg; A Saria; E Brodin; S Rosell; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

4.  Regulatory peptides in lower esophageal sphincter of pig and man.

Authors:  S Aggestrup; R Uddman; S L Jensen; R Håkanson; F Sundler; O Schaffalitzky de Muckadell; P Emson
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.